According to the World Health Organization (WHO) classification of tumors of the central nervous system, GBM is subdivided into isocitrate dehydrogenase (IDH)-wildtype or primary GBM, IDH-mutant, or secondary GBM and not otherwise specified (NOS) GBM [3]. This evidence concerns the gene IDH3A and glioblastoma.